KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Notes Payables (2022 - 2023)

Historic Notes Payables for Medpace Holdings (MEDP) over the last 2 years, with Q2 2023 value amounting to $55.0 million.

  • Medpace Holdings' Notes Payables fell 7797.36% to $55.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $55.0 million, marking a year-over-year decrease of 7797.36%. This contributed to the annual value of $50.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Medpace Holdings reported Notes Payables of $55.0 million as of Q2 2023, which was down 7797.36% from $115.0 million recorded in Q1 2023.
  • In the past 5 years, Medpace Holdings' Notes Payables ranged from a high of $249.7 million in Q2 2022 and a low of $50.0 million during Q4 2022